This site contains promotional content intended for UK Healthcare Professionals and other relevant decision makers | Not a HCP? Visit our  Public Site.

Adverse Event reporting can be found at the bottom of the page | Prescribing Information for the relevant medicine can be found adjacent to the below content and/or in the footer below. 

Sign In
Don’t have an account?
  • Products
  • Therapy Areas
  • Resources
  • Events & Webinars
  • Learning Zone
  • Podcasts
Bayer cross
BAYER FOR PROFESSIONALSYour Resource Portal
  • Ophthalmology
  • EYLEA® (aflibercept) 8 mg
  • EYLEA® (aflibercept) 2 mg
  • Oncology
  • Nubeqa® (darolutamide)
  • Xofigo®▼ (radium-223 dichloride)
  • Cardiology
  • Beyonttra®▼ (acoramidis)
  • Kerendia®▼ (finerenone)
  • Xarelto® (rivaroxaban)
  • Women's Health
  • Angeliq® (1mg estradiol hemihydrate and 2mg drospirenone)
  • Jaydess®▼ (13.5mg levonorgestrel)
  • Kyleena® (19.5mg levonorgestrel)
  • Mirena® (52mg levonorgestrel)
  • Qlaira® (estradiol valerate/dienogest)
  • Service Optimisation & Formularies
  • Risk Minimisation Materials
  • Ophthalmology
  • Oncology
  • Cardiology
  • Women's Health
  • Ophthalmology Resources
  • Oncology Resources
  • Cardiology Resources
  • Women's Health Resources
  • Ophthalmology Events & On Demand Webinars
  • Oncology Events & On Demand Webinars
  • Cardiology Events & On Demand Webinars
  • Women's Health Events & On Demand Webinars
  • Ophthalmology Learning Zone
  • Oncology Learning Zone
  • Cardiology Learning Zone
  • Women's Health Learning Zone
  • Ophthalmology Podcasts
  • Oncology Podcasts
  • Cardiology Podcasts
  • Women's Health Podcasts
closesearch
Recent Searches
    You are now leaving BayerPro

    The contents and the policies on the website you are visiting is not controlled by the BayerPRO team.
    Do you wish to continue?

    Women's Health hero banner image

    Products

    Angeliq® (1mg estradiol hemihydrate and 2mg drospirenone)
    Introduction to Angeliq
    Angeliq Prescribing Information
    PP-ANG-GB-0012, March 2026
    Jaydess® ▼ (13.5mg levonorgestrel)
    Jaydess Prescribing Information
    PP-PF-WHC-IUS-GB-0116, March 2026
    Kyleena® 19.5mg levonorgestrel
    Kyleena® Prescribing Information
    PP-PF-WHC-IUS-GB-0117, March 2026
    Mirena® (52mg levonorgestrel)
    Mirena® Prescribing Information
    PP-PF-WHC-IUS-GB-0114, March 2026
    Qlaira® (Estradiol valerate/dienogest)
    Qlaira Prescribing information
    PP-PF-WHC-IUS-GB-0115, March 2026

    Women's Health Therapy Areas

    Endometrial hyperplasia
    Mirena® Prescribing Information
    PP-PF-WHC-IUS-GB-0108, March 2025
    Menorrhagia (HMB - Heavy Menstural Bleeding)
    Assessing and managing women with heavy menstrual bleeding
    Mirena® Prescribing Information
    PP-PF-WHC-IUS-GB-0014, September 2024
    Menopause, Perimenopause and Endometrial Protection
    Learn more about the Menopause.
    PP-PF-WHC-IUS-GB-0080, April 2025
    Contraception
    Learn about contraception and helping your patients make the right choice. Kyleena®, Jaydess® ▼, Mirena®.
    Kyleena® Prescribing Information
    Mirena® Prescribing Information
    Jaydess® Prescribing Information
    PP-PF-WHC-IUS-GB-0013, August 2024

    Women's Health Learning Zone

    View more
    Urogenital Symptoms and Sexual Difficulties
    (5 mins) Often underreported and undertreated symptoms that significantly affect a woman's relationships.
    Mirena® Prescribing Information
    PP-PF-WHC-IUS-GB-0085 October 2024
    Musculoskeletal Symptoms, Anxiety, Low Mood and Brain Fog
    (4 mins) Causes for musculoskeletal (MSK) symptoms, how menopause can worsen existing anxiety and depression.
    Mirena® Prescribing Information
    PP-PF-WHC-IUS-GB-0084 October 2024
    Relationship Between Flushes and Sweats, Sleep and Mood
    (4 mins) Vasomotor symptoms (VMS), sleep disturbances, and mood changes are distressing menopause symptoms.
    Mirena® Prescribing Information
    PP-PF-WHC-IUS-GB-0083 October 2024
    HRT in the management of Menopause
    (5 mins) An overview of hormone replacement therapy (HRT) in the management of menopausal symptoms.
    Mirena® Prescribing Information
    PP-PF-WHC-IUS-GB-0100 March 2025

    Women's Health Resources

    View more
    Counselling patients
    Simple steps from INTRA to successfully counsel women about intrauterine contraception (IUC) in under 7 minutes.
    PP-PF-WHC-IUS-GB-0062, February 2024
    Patient Materials
    Useful, downloadable resources
    Kyleena® Prescribing Information
    Mirena® Prescribing Information
    PP-PF-WHC-IUS-GB-0111, December 2025
    Fitting Service Resources
    Access useful, downloadable IUS and LARC resources for HCPs and patients.
    Kyleena® Prescribing Information
    Mirena® Prescribing Information
    PP-PF-WHC-IUS-GB-0109, August 2025
    Fitter resources
    Step-by-step instructions to guide you through the preparation and fitting of IUS/IUD.
    Kyleena® Prescribing Information
    Mirena® Prescribing Information
    PP-PF-WHC-IUS-GB-0060, February 2024

    Women's Health Podcasts

    View more
    Socio-economic Burden of Menopause
    This podcast attempts to tackle a big question, what is the socio-economic burden of menopause?
    Mirena® Prescribing Information
    PP-PF-WHC-IUS-GB-0090, November 2024
    The Menopause Podcast
    Learn all about the menopause, from the symptoms to look out for to the impact on quality of life.
    Mirena® Prescribing Information
    PP-PF-WHC-IUS-GB-0089, November 2024
    The Perimenopause
    Dr Sarah Gray and Dr Kathryn Patrick provide their expertise on perimenopause.
    Mirena® Prescribing Information
    PP-PF-WHC-IUS-GB-0088, November 2024
    The Menstrual Cycle
    Symptoms experienced in this phase, the impact of menstrual disorders on women's lives and top tips to diagnose.
    Mirena® Prescribing Information
    PP-PF-WHC-IUS-GB-0087, November 2024

    Women's Health Events & Webinars

    View more
    Cultural Inequalities In Contraception Services
    Hear from Dr Radhika Vohra on how best to support your patients requiring contraception
    Kyleena® Prescribing Information
    Mirena® Prescribing Information
    PP-PF-WHC-IUS-GB-0113, March 2025
    Mirena (52mg levonorgestrel)- The Next Chapter
    Dr Diana Mansour present Mirena's launch webinar.
    Mirena® Prescribing Information
    Kyleena® Prescribing Information
    PP-PF-WHC-IUS-GB-0078, October 2024
    Supporting women with diabetes through the Perimenopause
    Hear from Dr Diana Mansour on how best to support your perimenopausal patients with diabetes
    Qlaira® Prescribing Information
    Mirena® Prescribing Information
    PP-PF-WHC-IUS-GB-0096, March 2025

    Register with BayerPRO

    To access additional resources, personalise your experience and keep up to date via electronic communications from Bayer.

     

    Don’t have an account?
    Areas of Interest
    Cardiovascular Content Card
    Cardiovascular
    Women's Health Content Card
    Women's Health
    Nephrology Content Card
    Nephrology
    Oncology Content Card
    Oncology
    Ophthalmology 1
    Ophthalmology
    Respiratory Content Card
    Respiratory